Certara Inc. (CERT) PT Lowered to $6 at BMO Capital May 12, 2026 09:00AM
Certara, Inc. (CERT) Misses Q1 EPS by 2c, Beats on Revenue; Offers FY26 Guidance May 11, 2026 06:29AM
Certara agrees to sell regulatory unit to Veristat for up to $135 million Apr 22, 2026 07:02AM
Barclays Downgrades Certara Inc. (CERT) to Equalweight Mar 6, 2026 06:19AM
Certara (CERT) Reiterated at Market Perform by Citizens: Fairly Valued Mar 3, 2026 05:12AM


Feb 27, 2026 09:23AM Craig-Hallum Downgrades Certara Inc. (CERT) to Hold
Feb 26, 2026 02:00PM Certara Inc. (CERT) PT Lowered to $10 at TD Cowen
Feb 26, 2026 01:08PM Certara Inc. (CERT) PT Lowered to $10 at Leerink Partners
Feb 26, 2026 06:16AM Certara, Inc. (CERT) Misses Q4 EPS by 2c
Feb 23, 2026 03:24PM Certara, Inc. (CERT) 1900 contracts of March 10 calls trade
Feb 14, 2026 10:00AM Which healthcare stocks are at risk from AI and which to buy
Jan 6, 2026 07:28AM Leerink Partners Upgrades Certara Inc. (CERT) to Outperform
Dec 12, 2025 06:25AM Certara Inc. (CERT) PT Lowered to $12 at Stephens
Nov 21, 2025 03:19AM Rothschild Redburn Starts Certara Inc. (CERT) at Buy
Nov 6, 2025 05:31PM Certara, Inc. (CERT) Tops Q3 EPS by 3c
Oct 30, 2025 04:16PM Certara launches AI-powered drug development platform
Sep 29, 2025 07:07AM Craig-Hallum Starts Certara Inc. (CERT) at Buy
Aug 7, 2025 10:24AM Certara Inc. (CERT) PT Lowered to $11.50 at Leerink Partners
Aug 6, 2025 05:33PM Certara, Inc. (CERT) Misses Q2 EPS by 3c
Jul 8, 2025 08:08AM Certara (CERT) expands clinical technology collaboration with Merck
Jul 3, 2025 07:39AM Morgan Stanley Assumes Certara Inc. (CERT) at Equalweight
May 8, 2025 06:03AM Barclays Upgrades Certara Inc. (CERT) to Overweight
May 6, 2025 08:52AM Citizens JMP Reiterates Market Perform Rating on Certara Inc. (CERT)
May 5, 2025 04:33PM Certara, Inc. (CERT) Tops Q1 EPS by 3c
Apr 14, 2025 08:16AM Certara (CERT) launches Non-Animal Navigator solution to help companies after FDA animal testing announcement
Apr 14, 2025 08:00AM Certara, Inc. (CERT) Announces $100M Share Buyback
Apr 1, 2025 08:00AM Certara, Inc. (CERT) Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Feb 28, 2025 03:18PM KeyBanc Reiterates Overweight Rating on Certara Inc. (CERT)
Feb 27, 2025 05:41AM TD Cowen Starts Certara Inc. (CERT) at Buy
Feb 26, 2025 04:32PM Certara, Inc. (CERT) Tops Q4 EPS by 3c
Nov 6, 2024 05:18PM Certara, Inc. (CERT) Tops Q3 EPS by 2c, provides guidance
Nov 5, 2024 06:54AM Certara Inc. (CERT) PT Lowered to $13 at Baird
Oct 16, 2024 04:15PM Certara, Inc. (CERT) Appoints John Reynders as New Independent Board Member
Oct 15, 2024 08:05AM Poseida Therapeutics (PSTX) Appoints Cynthia Collins to its Board
Oct 2, 2024 04:15PM Certara (CERT) Completes Acquisition of Chemaxon
Sep 27, 2024 02:40AM UBS Upgrades Certara Inc. (CERT) to Buy
Aug 15, 2024 04:15PM Certara (CERT) Launches Phoenix Version 8.5 Drug Development Software
Aug 6, 2024 05:18PM Certara, Inc. (CERT) Misses Q2 EPS by 3c
Jul 9, 2024 04:46PM Certara (CERT) to Acquire Chemaxon, Maintains 2024 Outlook
Jun 17, 2024 08:07AM Certara, Inc. (CERT) Launches Next Generation CoAuthor Generative AI Regulatory Writing Software